Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic
  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Sleep Number Announces First Quarter 2024 Results

  • Net sales of $470 million; adjusted EBITDA of $37 million slightly ahead of expectations
  • Reduced operating expenses by $24 million year-over-year (before restructuring costs) and remain on track to deliver $40 million to $45 million of operating expense reductions for the year
  • Free cash flow increased $21 million compared with the prior year’s first quarter
  • Reiterate full-year 2024 adjusted EBITDA outlook of $125 million to $145 million

Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended March 30, 2024.

“Our actions to increase operating model efficiencies drove first quarter adjusted EBITDA and gross margin rate ahead of our expectations. We also generated a significant year-over-year increase in free cash flow, as planned, and continue to prioritize paying down debt and reducing leverage,” said Shelly Ibach, Chair, President and CEO. “As we build a more durable operating model and as demand for our category improves from recessionary levels, we expect to capitalize on our significant opportunity as a sleep wellness technology company.”

First Quarter Overview

  • Net sales of $470 million declined 11% versus the prior year, including approximately four percentage points of pressure from year-over-year order backlog changes
  • Gross margin of 58.7% compared with 58.9% last year; the first quarter gross margin rate represented a significant sequential improvement from the back-half of the prior year
  • Operating expenses were reduced by $24 million to $260 million (before restructuring charges) compared with $284 million last year
  • Adjusted EBITDA of $37 million compared to $49 million last year, as ongoing cost reduction actions partially offset the year-over-year net sales decline

Cash Flows and Liquidity Review

  • Net cash provided by operating activities of $34 million in the first quarter, compared with $19 million for the same period last year
  • Free cash flow of $24 million in the first quarter, compared with $3 million for the same period last year
  • Leverage ratio of 4.2x EBITDAR at the end of the first quarter versus covenant maximum of 5.0x

Financial Outlook

The company reiterates its outlook for 2024 adjusted EBITDA of $125 million to $145 million. We continue to expect a mid-single digit net sales decline for the year on a low-single digit demand decline. The company expects approximately 100 basis points of gross margin rate improvement and $14 million of restructuring charges for the year. The company expects to generate $60 million to $80 million of free cash flow with capital expenditures of $30 million.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation

Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our nearly 26 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 4,000 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in over 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom. and investor relations sites, or SleepNumber.com

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the statement that the company is building a more durable business model as the bedding industry demand environment improves from recessionary levels and the company’s financial outlook, including the company’s expected adjusted EBITDA, in 2024 and future capital expenditures and operating expenses, are forward-looking statements subject to certain risks and uncertainties including, among others, changes in economic conditions and consumer sentiment and related impacts on discretionary consumer spending; increases in interest rates, which have increased the cost of servicing our indebtedness; availability of attractive and cost-effective consumer credit options; ability to achieve savings and efficiencies from cost savings plans related to operating model transformation and to avoid unexpected adverse effects; dependence on, and ability to maintain working relationships with key suppliers and third parties; fluctuations in commodity costs or third-party delivery or logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, foreign regulation, geo-political turmoil, war, pandemics, labor challenges, foreign currency fluctuations, inflation, and climate or other disasters, and resulting supply shortages and production and delivery delays and disruptions; operating with minimal levels of inventory, which may leave us vulnerable to supply shortages; the effectiveness of our marketing strategy and promotional efforts; the execution of our Total Retail distribution strategy; ability to achieve and maintain high levels of product quality and to improve and expand the product line; ability to protect our technology, trademarks, and brand and the adequacy of our intellectual property rights; ability to effectively compete; risks of disruption in the operation of our facilities and operations, including manufacturing, assembly, distribution, logistics, field services, home delivery, headquarters, product development, retail or customer service operations; ability to comply with existing and changing government regulations and laws; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; our ability to identify and withstand cyber threats that could compromise the security of our systems, result in a data breach or business disruption; risks associated with advancements in or adoption of artificial intelligence technologies; our ability, and the ability of our suppliers and vendors, to attract, retain and motivate qualified and effective personnel; the volatility of Sleep Number stock, our removal from various stock indices, and the potential negative effects of shareholder activism or of changes in coverage by securities analysts; environmental, social and governance risks, including increasing regulation and stakeholder expectations; and our ability to adapt to climate change and readiness for legal or regulatory responses thereto.​ Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K and other periodic reports. We have no obligation to publicly update or revise any of these forward-looking statements.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

Three Months Ended

 

March 30,

2024

 

% of

Net Sales

 

April 1,

2023

 

% of

Net Sales

Net sales

$

470,449

 

 

100.0

%

 

$

526,527

 

100.0

%

Cost of sales

 

194,275

 

 

41.3

%

 

 

216,262

 

41.1

%

Gross profit

 

276,174

 

 

58.7

%

 

 

310,265

 

58.9

%

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

208,512

 

 

44.3

%

 

 

230,488

 

43.8

%

General and administrative

 

39,079

 

 

8.3

%

 

 

39,401

 

7.5

%

Research and development

 

12,441

 

 

2.6

%

 

 

14,443

 

2.7

%

Restructuring costs

 

10,600

 

 

2.3

%

 

 

 

%

Total operating expenses

 

270,632

 

 

57.5

%

 

 

284,332

 

54.0

%

Operating income

 

5,542

 

 

1.2

%

 

 

25,933

 

4.9

%

Interest expense, net

 

12,299

 

 

2.6

%

 

 

9,102

 

1.7

%

(Loss) income before income taxes

 

(6,757

)

 

(1.4

%)

 

 

16,831

 

3.2

%

Income tax expense

 

725

 

 

0.2

%

 

 

5,366

 

1.0

%

Net (loss) income

$

(7,482

)

 

(1.6

%)

 

$

11,465

 

2.2

%

 

 

 

 

 

 

 

 

Net (loss) income per share – basic

$

(0.33

)

 

 

 

$

0.51

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share – diluted

$

(0.33

)

 

 

 

$

0.51

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

 

22,506

 

 

 

 

 

22,296

 

 

Dilutive effect of stock-based awards

 

 

 

 

 

 

287

 

 

Diluted weighted-average shares outstanding

 

22,506

 

 

 

 

 

22,583

 

 

 

For the three months ended March 30, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited – in thousands, except per share amounts)

subject to reclassification

 

 

March 30,

2024

 

December 30,

2023

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

2,068

 

 

$

2,539

 

Accounts receivable, net of allowances of $1,090 and $1,437, respectively

 

21,833

 

 

 

26,859

 

Inventories

 

100,904

 

 

 

115,433

 

Prepaid expenses

 

20,655

 

 

 

16,660

 

Other current assets

 

35,589

 

 

 

44,637

 

Total current assets

 

181,049

 

 

 

206,128

 

Non-current assets:

 

 

 

Property and equipment, net

 

167,037

 

 

 

179,503

 

Operating lease right-of-use assets

 

387,942

 

 

 

395,411

 

Goodwill and intangible assets, net

 

66,579

 

 

 

66,634

 

Deferred income taxes

 

21,181

 

 

 

20,253

 

Other non-current assets

 

84,685

 

 

 

82,951

 

Total assets

$

908,473

 

 

$

950,880

 

Liabilities and Shareholders’ Deficit

 

 

 

Current liabilities:

 

 

 

Borrowings under revolving credit facility

$

523,500

 

 

$

539,500

 

Accounts payable

 

125,304

 

 

 

135,901

 

Customer prepayments

 

50,262

 

 

 

49,143

 

Accrued sales returns

 

22,415

 

 

 

22,402

 

Compensation and benefits

 

28,296

 

 

 

28,273

 

Taxes and withholding

 

16,661

 

 

 

17,134

 

Operating lease liabilities

 

81,300

 

 

 

81,760

 

Other current liabilities

 

58,454

 

 

 

61,958

 

Total current liabilities

 

906,192

 

 

 

936,071

 

Non-current liabilities:

 

 

 

Operating lease liabilities

 

343,447

 

 

 

351,394

 

Other non-current liabilities

 

104,697

 

 

 

105,343

 

Total non-current liabilities

 

448,144

 

 

 

456,737

 

Total liabilities

 

1,354,336

 

 

 

1,392,808

 

Shareholders’ deficit:

 

 

 

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

Common stock, $0.01 par value; 142,500 shares authorized, 22,326 and 22,235 shares issued and outstanding, respectively

 

223

 

 

 

222

 

Additional paid-in capital

 

20,262

 

 

 

16,716

 

Accumulated deficit

 

(466,348

)

 

 

(458,866

)

Total shareholders’ deficit

 

(445,863

)

 

 

(441,928

)

Total liabilities and shareholders’ deficit

$

908,473

 

 

$

950,880

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

subject to reclassification

 

 

Three Months Ended

 

March 30,

2024

 

April 1,

2023

Cash flows from operating activities:

 

 

 

Net (loss) income

$

(7,482

)

 

$

11,465

 

Adjustments to reconcile net income to net cash provided by

operating activities:

 

 

 

Depreciation and amortization

 

17,487

 

 

 

18,218

 

Stock-based compensation

 

4,117

 

 

 

4,639

 

Net loss on disposals and impairments of assets

 

2,500

 

 

 

12

 

Deferred income taxes

 

(928

)

 

 

(3,252

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

5,026

 

 

 

2,717

 

Inventories

 

14,529

 

 

 

(2,747

)

Income taxes

 

1,587

 

 

 

8,736

 

Prepaid expenses and other assets

 

5,473

 

 

 

(11,056

)

Accounts payable

 

(2,765

)

 

 

(574

)

Customer prepayments

 

1,119

 

 

 

(4,639

)

Accrued compensation and benefits

 

30

 

 

 

(593

)

Other taxes and withholding

 

(2,060

)

 

 

(711

)

Other accruals and liabilities

 

(4,888

)

 

 

(3,634

)

Net cash provided by operating activities

 

33,745

 

 

 

18,581

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Purchases of property and equipment

 

(9,308

)

 

 

(15,556

)

Issuance of notes receivable

 

(2,942

)

 

 

 

Net cash used in investing activities

 

(12,250

)

 

 

(15,556

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Net decrease in short-term borrowings

 

(21,396

)

 

 

(384

)

Repurchases of common stock

 

(570

)

 

 

(3,363

)

Proceeds from issuance of common stock

 

 

 

 

389

 

Net cash used in financing activities

 

(21,966

)

 

 

(3,358

)

 

 

 

 

Net decrease in cash and cash equivalents

 

(471

)

 

 

(333

)

Cash and cash equivalents, at beginning of period

 

2,539

 

 

 

1,792

 

Cash and cash equivalents, at end of period

$

2,068

 

 

$

1,459

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Supplemental Financial Information

(unaudited)

 

 

Three Months Ended

 

March 30,

2024

 

April 1,

2023

Percent of sales:

 

 

 

Retail stores

 

88.2

%

 

 

87.1

%

Online, phone, chat and other

 

11.8

%

 

 

12.9

%

Total Company

 

100.0

%

 

 

100.0

%

 

 

 

 

Sales change rates:

 

 

 

Retail comparable-store sales

 

(10

%)

 

 

1

%

Online, phone and chat

 

(19

%)

 

 

(18

%)

Total Retail comparable sales change

 

(11

%)

 

 

(2

%)

Net opened/closed stores and other

 

0

%

 

 

2

%

Total Company

 

(11

%)

 

 

0

%

 

 

 

 

Stores open:

 

 

 

Beginning of period

 

672

 

 

 

670

 

Opened

 

6

 

 

 

12

 

Closed

 

(17

)

 

 

(11

)

End of period

 

661

 

 

 

671

 

 

 

 

 

Other metrics:

 

 

 

Average sales per store ($ in 000's) 1

$

2,786

 

 

$

3,239

 

Average sales per square foot 1

$

903

 

 

$

1,060

 

Stores > $2 million net sales 2

 

63

%

 

 

75

%

Stores > $3 million net sales 2

 

23

%

 

 

36

%

Average revenue per smart bed unit 3

$

5,765

 

 

$

5,848

 

1

Trailing twelve months Total Retail comparable sales per store open at least one year.

2

Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

3

Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

(in thousands)

 

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

 

 

Three Months Ended

 

Trailing Twelve Months Ended

 

March 30,

2024

 

April 1,

2023

 

March 30,

2024

 

April 1,

2023

Net (loss) income

$

(7,482

)

 

$

11,465

 

$

(34,234

)

 

$

46,001

Income tax expense (benefit)

 

725

 

 

 

5,366

 

 

(9,107

)

 

 

17,437

Interest expense

 

12,299

 

 

 

9,102

 

 

45,892

 

 

 

25,960

Depreciation and amortization

 

17,145

 

 

 

17,991

 

 

71,633

 

 

 

68,934

Stock-based compensation

 

4,117

 

 

 

4,639

 

 

14,333

 

 

 

13,729

Restructuring costs 1

 

10,600

 

 

 

 

 

26,328

 

 

 

Asset impairments

 

 

 

 

12

 

 

660

 

 

 

204

Adjusted EBITDA

$

37,404

 

 

$

48,575

 

$

115,505

 

 

$

172,265

 

1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

Free Cash Flow

(in thousands)

 

 

Three Months Ended

 

Trailing Twelve Months Ended

 

March 30,

2024

 

April 1,

2023

 

March 30,

2024

 

April 1,

2023

Net cash provided by operating activities

$

33,745

 

$

18,581

 

$

6,136

 

 

$

30,161

 

Subtract: Purchases of property and equipment

 

9,308

 

 

15,556

 

 

50,808

 

 

 

65,406

 

Free cash flow

$

24,437

 

$

3,025

 

$

(44,672

)

 

$

(35,245

)

 

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Net Leverage Ratio under Revolving Credit Facility

(in thousands)

 

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the November 2, 2023 amendment are presented below. The prior year is presented in conformity with the November 2, 2023 amendment.

 

 

Trailing Twelve Months Ended

 

March 30,

2024

 

April 1,

2023

Borrowings under revolving credit facility

$

523,500

 

$

470,600

Outstanding letters of credit

 

7,147

 

 

7,147

Finance lease obligations

 

300

 

 

392

Consolidated funded indebtedness

$

530,947

 

$

478,139

Operating lease liabilities 1

 

424,746

 

 

436,939

Total debt including operating lease liabilities (a)

$

955,693

 

$

915,078

 

 

 

 

Adjusted EBITDA (see above)

$

115,505

 

$

172,265

Consolidated rent expense

 

112,233

 

 

111,593

Consolidated EBITDAR (b)

$

227,738

 

$

283,858

Net Leverage Ratio under revolving credit facility (a divided by b)

4.2 to 1.0

 

3.2 to 1.0

1

Reflects operating lease liabilities included in our financial statements under ASC 842. The prior period has been updated to reflect this calculation.

Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Return on Invested Capital (Adjusted ROIC)

(in thousands)

 

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 

 

Trailing Twelve Months Ended

 

March 30,

2024

 

April 1,

2023

Adjusted net operating profit after taxes (Adjusted NOPAT)

 

 

 

Operating income

$

2,550

 

 

$

89,398

 

Add: Operating lease interest 1

 

27,882

 

 

 

26,487

 

Less: Income taxes 2

 

(7,479

)

 

 

(29,674

)

Adjusted NOPAT

$

22,953

 

 

$

86,211

 

 

 

 

 

Average adjusted invested capital

 

 

 

Total deficit

$

(445,863

)

 

$

(425,047

)

Add: Long-term debt 3

 

523,800

 

 

 

470,991

 

Add: Operating lease liabilities 4

 

424,746

 

 

 

436,939

 

Total adjusted invested capital at end of period

$

502,683

 

 

$

482,883

 

 

 

 

 

Average adjusted invested capital 5

$

505,498

 

 

$

423,287

 

 

 

 

 

Adjusted ROIC 6

 

4.5

%

 

 

20.4

%

1

Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.

2

Reflects annual effective income tax rates, before discrete adjustments, of 24.6% and 25.6% for March 30, 2024 and April 1, 2023, respectively.

3

Long-term debt includes existing finance lease liabilities.

4

Reflects operating lease liabilities included in our financial statements under ASC 842.

5

Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

6

Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

 

 

 

Note - the Company's adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842.

 

GAAP - generally accepted accounting principles in the U.S.

 

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Reported to Adjusted Statements of Operations Data Reconciliation

(in thousands, except per share amounts)

 

 

Three Months Ended

 

March 30, 2024

 

April 1, 2023

 

 

 

 

 

 

 

 

 

As

Reported

 

Restructuring

Costs 1, 2

 

As

Adjusted

 

As

Reported

Operating income

$

5,542

 

 

$

10,600

 

$

16,142

 

$

25,933

Interest expense, net

 

12,299

 

 

 

 

 

12,299

 

 

9,102

(Loss) income before income taxes

 

(6,757

)

 

 

10,600

 

 

3,843

 

 

16,831

Income tax expense

 

725

 

 

 

2,512

 

 

3,237

 

 

5,366

Net (loss) income

$

(7,482

)

 

$

8,088

 

$

606

 

$

11,465

 

 

 

 

 

 

 

 

Net (loss) income per share:

 

 

 

 

 

 

 

Basic

$

(0.33

)

 

$

0.36

 

$

0.03

 

$

0.51

Diluted

$

(0.33

)

 

$

0.36

 

$

0.03

 

$

0.51

 

 

 

 

 

 

 

 

Basic Shares

 

22,506

 

 

 

22,506

 

 

22,506

 

 

22,296

Diluted Shares

 

22,506

 

 

 

22,506

 

 

22,506

 

 

22,583

1

Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

2

The income tax expense is calculated using the estimated U.S. federal and state statutory tax rate of 23.7%.

Note - Our "as adjusted" data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates year-over-year comparisons for investors and financial analysts.

 

GAAP - generally accepted accounting principles

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.